Innoviva (INVA) Cash & Equivalents Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 89.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.00% |
| Dec 31, 2025 | 80.66% |
| Sep 30, 2025 | 82.83% |
| Jun 30, 2025 | 83.19% |
| Mar 31, 2025 | 78.91% |
| Dec 31, 2024 | 57.59% |
| Sep 30, 2024 | 44.80% |
| Jun 30, 2024 | 25.42% |
| Mar 31, 2024 | 23.82% |
| Dec 31, 2023 | -33.51% |
| Sep 30, 2023 | -40.16% |
| Jun 30, 2023 | -38.99% |
| Mar 31, 2023 | -33.56% |
| Dec 31, 2022 | 44.42% |
| Sep 30, 2022 | 122.62% |
| Jun 30, 2022 | 555.45% |
| Mar 31, 2022 | -23.36% |
| Dec 31, 2021 | -18.24% |
| Sep 30, 2021 | -71.80% |
| Jun 30, 2021 | -89.53% |
| Mar 31, 2021 | -19.63% |
| Dec 31, 2020 | -11.37% |
| Sep 30, 2020 | 177.08% |
| Jun 30, 2020 | 191.05% |
| Mar 31, 2020 | 440.25% |
| Dec 31, 2019 | 345.55% |
| Sep 30, 2019 | 255.75% |
| Jun 30, 2019 | 62.74% |
| Mar 31, 2019 | 140.07% |
| Dec 31, 2018 | -14.89% |
| Sep 30, 2018 | -64.88% |
| Jun 30, 2018 | -31.66% |
| Mar 31, 2018 | -83.02% |
| Dec 31, 2017 | -37.86% |
| Sep 30, 2017 | 48.53% |
| Jun 30, 2017 | 13.01% |
| Mar 31, 2017 | 5.29% |
| Dec 31, 2016 | -25.86% |
| Sep 30, 2016 | 18.35% |
| Jun 30, 2016 | -24.49% |
| Mar 31, 2016 | 7.50% |
| Dec 31, 2015 | 64.44% |
| Sep 30, 2015 | -34.15% |
| Jun 30, 2015 | -28.10% |
| Mar 31, 2015 | 12.70% |
| Dec 31, 2014 | -32.55% |
| Sep 30, 2014 | -30.44% |
| Jun 30, 2014 | 4.42% |
| Mar 31, 2014 | -52.92% |
| Dec 31, 2013 | 51.30% |
| Sep 30, 2013 | 53.15% |
| Jun 30, 2013 | 23.68% |
| Mar 31, 2013 | 1,759.33% |
| Dec 31, 2012 | 111.82% |
| Sep 30, 2012 | 78.90% |
| Jun 30, 2012 | 77.70% |
| Mar 31, 2012 | -90.32% |
| Dec 31, 2011 | -72.58% |
| Sep 30, 2011 | -0.58% |
| Jun 30, 2011 | 30.03% |
| Dec 31, 2010 | 243.54% |